Q2 2026 13F · SEC CIK 64803
CVS HEALTH Corp
CorporationFiled 2026-08-06 for Q2 2026. Open the filing ↗ · All SEC filings ↗
- Reported 13F value
- $225.2M
- Reported positions
- 21
- Top holdings a year, 3 yrs
- +14.3%
- Average holding period
- 2 qtrs
CVS HEALTH Corp is a corporation that reported 21 positions worth $225.2M in its Q2 2026 13F, filed 2026-08-06. Its largest holdings were Ishares Tr (IGSB, 20.7%), Ishares Tr (IGIB, 10.4%), Ishares Tr (IEI, 9.5%). A portfolio copying its top holdings returned 14.3% a year over the last 3 years, against 20.4% for the S&P 500.
CVS HEALTH Corp holdings all 21 positions.
Weights are shares of the filer's total reported 13F value, compared with Q1 2026. Share changes may reflect splits; weight changes also reflect price moves. A 13F shows long US-listed positions only, up to 135 days after the fact.
| Stock | % of 13F value | Share change | Reported value |
|---|---|---|---|
| IGSBIshares Tr | 20.7% | +202.3% | $46.6M |
| IGIBIshares Tr | 10.4% | +374.4% | $23.4M |
| IEIIshares Tr | 9.5% | +0.0% | $21.5M |
| SHYIshares Tr | 9.4% | +10.7% | $21.2M |
| USHYiShares Broad USD High Yield Corporate B | 7.9% | +37.3% | $17.7M |
| EMBIshares Tr | 7.7% | +68.2% | $17.4M |
| AGGIshares Tr | 6.6% | +0.0% | $14.8M |
| VCSHVanguard Scottsdale Fds | 4.2% | +0.0% | $9.5M |
| IGLBIshares Tr | 3.9% | +75.0% | $8.8M |
| LQDIshares Tr | 3.4% | — | $7.6M |
| HYGIshares Tr | 3.2% | — | $7.2M |
| VGITVanguard Scottsdale Fds | 2.2% | +0.0% | $5.0M |
| JAAAJanus Detroit Str Tr | 2.2% | +0.0% | $5.0M |
| JPSTJ P Morgan Exchange Traded F | 2.2% | +0.0% | $5.0M |
| VCITVanguard Scottsdale Fds | 2.2% | +0.0% | $5.0M |
| TLTIshares Tr | 1.9% | +150.0% | $4.3M |
| IEFIshares Tr | 1.5% | +0.0% | $3.3M |
| DRAMRoundhill ETF Trust | 0.3% | — | $739K |
| COMDirexion Shares ETF Trust | 0.2% | — | $489K |
| RSPInvesco Exchange Traded Fd T | 0.2% | -91.3% | $426K |
| PRUPrudential Finl Inc | 0.1% | +0.0% | $290K |
What CVS HEALTH Corp bought and sold in Q2 2026, against Q1 2026.
New positions
- LQD Ishares Tr3.4% of 13F
- HYG Ishares Tr3.2% of 13F
- DRAM Roundhill ETF Trust0.3% of 13F
- COM Direxion Shares ETF Trust0.2% of 13F
Added to
- IGIB Ishares Tr+374.4% shares
- IGSB Ishares Tr+202.3% shares
- TLT Ishares Tr+150.0% shares
- IGLB Ishares Tr+75.0% shares
- EMB Ishares Tr+68.2% shares
- USHY iShares Broad USD High Yield Corporate B+37.3% shares
- SHY Ishares Tr+10.7% shares
Reduced
- RSP Invesco Exchange Traded Fd T-91.3% shares
Sold out
- SPY State Str Spdr S&p 500 ETF Twas 26.8%
- XLV Select Sector Spdr Trwas 0.8%
- VEA Vanguard Ftse Developed Markets Index Fuwas 0.6%
- XLU Select Sector Spdr Trwas 0.5%
- IEMG Ishares Incwas 0.5%
- XLI Select Sector Spdr Trwas 0.5%
- VGLT Vanguard Scottsdale Fdswas 0.4%
- UUP Invesco Db US Dlr Index Trwas 0.4%
Share counts compared with the Q1 2026 13F; a split also changes share counts.
How the holdings did against the S&P 500.
- 1 year
- —
- 3 years
- +14.3% /yr
- S&P 500 +20.4%
- 5 years
- —
A portfolio of the filer's 20 largest 13F positions, weighted by value, bought the trading day after each 13F was filed and held until the next one was: what copying this filer could have earned. 13Fs show long US-listed positions only, so this is an estimate of the stock picks, not the fund's reported returns.
Reported 13F value by quarter.
| Quarter | 13F value | Positions |
|---|---|---|
| Q2 2026 | $225.2M | 21 |
| Q1 2026 | $212.3M | 33 |
| Q4 2025 | $135.3M | 9 |
| Q3 2024 | $230.2M | 5 |
| Q2 2024 | $216.8M | 6 |
| Q1 2024 | $211.8M | 6 |
| Q4 2023 | $193.7M | 6 |
| Q3 2023 | $187.0M | 9 |
| Q2 2023 | $193.4M | 9 |
| Q1 2023 | $168.0M | 9 |
| Q4 2022 | $116.0M | 6 |
| Q3 2022 | $104.1M | 7 |
Questions about CVS HEALTH Corp's portfolio
What stocks does CVS HEALTH Corp own?
CVS HEALTH Corp's latest 13F, for Q2 2026 and filed Aug 6, 2026, lists 21 positions worth $225.2M. The largest are Ishares Tr (IGSB) at 20.7%, Ishares Tr (IGIB) at 10.4%, Ishares Tr (IEI) at 9.5%, Ishares Tr (SHY) at 9.4% and iShares Broad USD High Yield Corporate B (USHY) at 7.9%.
What did CVS HEALTH Corp buy last quarter?
In Q2 2026, CVS HEALTH Corp added a new position in Ishares Tr (LQD), a new position in Ishares Tr (HYG), a new position in Roundhill ETF Trust (DRAM), a new position in Direxion Shares ETF Trust (COM), Ishares Tr (IGIB) (+374.4% shares), Ishares Tr (IGSB) (+202.3% shares) and Ishares Tr (TLT) (+150.0% shares), compared with its Q1 2026 filing.
What did CVS HEALTH Corp sell last quarter?
In Q2 2026, CVS HEALTH Corp sold all of State Str Spdr S&p 500 ETF T (SPY), sold all of Select Sector Spdr Tr (XLV), sold all of Vanguard Ftse Developed Markets Index Fu (VEA), sold all of Select Sector Spdr Tr (XLU), sold all of Ishares Inc (IEMG) and Invesco Exchange Traded Fd T (RSP) (-91.3% shares), compared with its Q1 2026 filing.
How has CVS HEALTH Corp's portfolio performed?
A portfolio copying CVS HEALTH Corp's 20 largest 13F holdings each quarter, from the day each filing was public, returned +14.3% a year over the last 3 years, against +20.4% for the S&P 500.
When is CVS HEALTH Corp's next 13F filing due?
13F filings are due 45 days after each quarter ends. CVS HEALTH Corp's filing for the quarter ending Sep 30, 2026 is due by Nov 14, 2026; this page updates the day after it is published.